Yüklüyor......
Amelioration of metabolic syndrome by metformin associates with reduced indices of low-grade inflammation independently of the gut microbiota
Metformin beneficially impacts several aspects of metabolic syndrome including dysglycemia, obesity, and liver dysfunction, thus making it a widely used frontline treatment for early-stage type 2 diabetes, which is associated with these disorders. Several mechanisms of action for metformin have been...
Kaydedildi:
| Yayımlandı: | Am J Physiol Endocrinol Metab |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Physiological Society
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6962505/ https://ncbi.nlm.nih.gov/pubmed/31573841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00245.2019 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|